Differences in Rural Versus Urban Patients With Prostate Cancer in Diagnosis and Treatment: An Analysis of a Population-Based Cohort
View abstract on PubMed
Summary
This summary is machine-generated.Rural prostate cancer patients face significant disparities in care, including fewer biopsy cores and less use of active surveillance for low-risk disease compared to urban counterparts.
Area Of Science
- Oncology
- Public Health
- Health Services Research
Background
- Rural populations experience greater barriers to cancer care and poorer outcomes.
- Prostate cancer patients in rural areas may have reduced access and different treatment patterns compared to urban patients.
Purpose Of The Study
- To compare prostate cancer diagnosis, access to care, and treatment between rural and urban patients.
- To investigate geographic disparities in prostate cancer care delivery.
Main Methods
- Utilized a population-based prospective cohort: the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study.
- Classified residence as urban (RUCC 1-3) or rural (RUCC 4-9) using the 2013 rural-urban continuum code.
- Compared diagnostic and treatment differences based on geographic residence.
Main Results
- Rural patients (25% of cohort) were less likely to be White, had lower income/education, and received fewer biopsy cores (47.1% vs 35.7%).
- Rural patients had less multidisciplinary consultation (40.8% vs 47.6%) and less active surveillance/observation, particularly for low-risk cancer (33.2% vs 40.7%).
- Multivariable analysis confirmed rural residence is associated with less active surveillance over radical treatment for low-risk prostate cancer (OR, 0.49).
Conclusions
- Rural prostate cancer patients encounter clinically meaningful differences in care, including diagnostic biopsy and treatment utilization.
- Fewer biopsy cores, less multidisciplinary consultation, and reduced use of active surveillance for low-risk disease highlight rural-urban disparities.
- Further research is needed to develop interventions addressing these care gaps and mitigate disparities.
Related Concept Videos
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Descriptive Statistics: These provide basic...

